| Recruiting | 4 | 120 | US | Dupilumab, Dupixent, Benralizumab, Fasenra | University of California, San Diego, Mayo Clinic, Yale University, University of Arizona, Harvard University, Brigham and Women's Hospital, National Heart, Lung, and Blood Institute (NHLBI) | Moderate to Severe Asthma | 06/27 | 01/28 | | |
NCT05172011: Understanding the Long-term Impact of COVID on Children and Families |
|
|
| Active, not recruiting | N/A | 15028 | US | | NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI) | SARS-CoV-2 Infection | 04/27 | 05/27 | | |